Skip to content
Already have a referral from your rheumatologist or neurologist? Book a session
mymee for payers mymee for payers

1% of plan members = 20% of Rx costs*

In the US, autoimmune drugs cost over $100B a year and comprise 54% of specialty Rx growth associated with autoimmune biologics and targeted therapies. However, on average, 40% of rheumatic patients are non-responders in clinical trials and over 70% do not sustain remission in the real world. These patients remain at risk of exposure to unique sensitivities in their exposome that drive worsening symptoms despite prescribed medication.

*Sources: Prime Therapeutics, Inc, CVS Payor Solutions, Published meta analysis of RA, PsA, AS IBM claims data, real world evidence studies & RCTs

Mymee’s proprietary, personalized trial & care platform improves patient outcomes to deliver proven & measurable value impact for payers

Layer 3 (2)

Average gross annual Rx savings of $11,328 per patient on biologics defined by payer audited script reduction


Statistically significant and clinically meaningful change among symptomatic patients across 10 HRQoL domains as measured by PROMIS-29. The more severe the symptom, the greater the average improvement

Layer 2

> 40% mean reduction in 59 patient-reported symptoms surveyed in personalized trials


Reduction in average # of prescription drugs among patients who were symptomatic at baseline

Learn more about supporting autoimmune patients through personalized trial & care

Read on for additional articles and insights related to Mymee’s research and use of coach-led personalized trials to guide statistically significant improvements in quality of life.  

Mymee Patients Reverse Autoimmune Disease Flares (2)

PR Newswire: Mymee's Personalized Trial & Care Platform Helps Autoimmune Disease Patients Reverse Flares, New Research Shows


Rheumatology Network: Self-Advocacy Platform Allows Patients with Autoimmune Diseases to Discover Triggers, Improve Disease Management

RA Patient Experiences Improvement With Mymee

PR Newswire: New Real-world Study Demonstrates Connection Between
Long COVID and Rheumatic Autoimmune Disease Symptoms and Environmental Triggers

Woman receives virtual lupus support through Mymee

ACR Meeting Abstract: How Becoming Engaged in My Care with Specialized Tools and Support Helped Me Find My Personal Lupus Triggers and Regain Control of My Health (Patient Perspective)

Screenshot 2023-03-21 at 6.13.05 PM

Journal of Medical Internet Research: Health-Related Quality of Life Improvements in Systemic Lupus Erythematosus